Our Portfolio List

Here you’ll find a selection of our previous clinical research trials.
Explore the results and learn more about what we do.

A Study to Determine the Safety and Efficacy of TG-C in Subjects with Kellgren and Lawrence Grade 2 or 3 OA of the Knee

NCT03203330 / TGC12301

July 10, 2024

Kolon TissueGene, Inc.

Placebo-Controlled Safety Study f Ritlecitinib (Pf-06651600) in Adults with Alopecia Areata (Allegro2a)

NCT04517864 / B7981037

May 7, 2024

Pfizer

Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients with Chronic Heart Failure

NCT02884206 / CLCZ696B2320

May 16, 2022

Novartis Pharmaceuticals

A Study of E2027 in Participants with Dementia with Lewy Bodies (DLB) or Parkinson's Disease

NCT04764669 / E2027-A001-203

January 27, 2022

Eisai Inc.

Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants with NDD

NCT02680574 / AKB-6548-CI-0015

July 31, 2020

Akebia Therapeutics

Evaluate Vadadustat for the Correction of Anemia in Participants with Non-dialysis-dependent CKD

NCT02648347 / AKB-6548-CI-0014

July 31, 2020

Akebia Therapeutics

A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with CKD

NCT03036150 / D169AC00001

June 12, 2020

AstraZeneca

BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients

NCT03394989 / U-FS-MU-AS3120

March 31, 2020

Cipla Ltd.

GLORIA-AF Registry Program - Second and Third Phases

NCT01468701 / 1160.129

January 10, 2020

Boehringer Ingelheim

Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus

NCT01986881 / B1521021

December 27, 2019

Merck Sharp & Dohme LLC

Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients with Mild to Moderate HF

NCT02874794 / CLCZ696BUS08

January 26, 2019

Novartis Pharmaceuticals

A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo

NCT02451137 / LPS14347

August 9, 2018

Sanofi

Long-term Safety and Efficacy of Sirukumab in Participants with RA

NCT01856309 / CNTO136ARA3004

April 30, 2018

Janssen Research & Development, LLC

Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary

NCT02155660 / D3251C00004

April 9, 2018

AstraZeneca

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)

NCT02940886 / P-Monofer-IDA-03

March 28, 2018

Pharmacosmos A/S

Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 Diabetes

NCT02413398 / D1690C00024

November 7, 2017

AstraZeneca

A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents with Uncontrolled Asthma

NCT02194699 / D2210C00008

September 21, 2017

AstraZeneca

Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)

NCT01701817 / Orbit AF II

July 12, 2017

Janssen Scientific Affairs, LLC

Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects with Chronic Kidney Disease

NCT02496884 / DS5565-A-U307

July 6, 2017

Daiichi Sankyo

An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated with Fibromyalgia

NCT02234583 / DS5565-A-E312

April 19, 2017

Daiichi Sankyo

A Multicenter Assessment of ALD403 in Chronic Migraine

NCT02275117 / ALD403-CLIN-005

November 1, 2016

Alder Biopharmaceuticals, Inc.

Treatment of Pain Associated with Fibromyalgia

NCT02146430 / DS5565-A-E309

July 14, 2016

Daiichi Sankyo

A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody in Patients with Active Rheumatoid Arthritis

NCT01606761 / CNTO136ARA3003

January 12, 2016

Janssen Research & Development, LLC

Migraine Study in Adolescent Patients

NCT00843024 / 107979

June 1, 2010

GlaxoSmithKline

Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina (T89 phase 2)

NCT00797953 / T89-005-0003-US

January 1, 2010

Tasly Pharmaceuticals, Inc.

Clinical Trial of SB-509-0401 in Subjects with Diabetic Neuropathy

NCT00110500 / SB-509-0401

January 1, 2008

Sangamo Therapeutics

Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)

NCT00151333 / 3098A1-200

April 1, 2005

Pfizer

Study Evaluating EAA-090 in Adult Outpatients with Neuropathic Pain Associated with Diabetic Neuropathy

NCT00073034 / 0912A2-212

December 1, 2004

Pfizer

Our Portfolio List

Here you’ll find a selection of our previous clinical research trials. Explore the results and learn more about what we do.

A Study to Determine the Safety and Efficacy of TG-C in Subjects with Kellgren and Lawrence Grade 2 or 3 OA of the Knee

Placebo-Controlled Safety Study f Ritlecitinib (Pf-06651600) in Adults with Alopecia Areata (Allegro2a)

Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients with Chronic Heart Failure

A Study of E2027 in Participants with Dementia with Lewy Bodies (DLB) or Parkinson's Disease

Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants with NDD

Evaluate Vadadustat for the Correction of Anemia in Participants with Non-dialysis-dependent CKD

A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with CKD

BE Study of Fluticasone Propionate/​Salmeterol Inhalation Powder in Asthma Patients

GLORIA-AF Registry Program - Second and Third Phases

Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus

Study of Effects of Sacubitril/​Valsartan vs. Enalapril on Aortic Stiffness in Patients with Mild to Moderate HF

A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo

Long-term Safety and Efficacy of Sirukumab in Participants with RA

Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary

Iron Isomaltoside/​Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)

Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 Diabetes

A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents with Uncontrolled Asthma

Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)

Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects with Chronic Kidney Disease

An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated with Fibromyalgia

A Multicenter Assessment of ALD403 in Chronic Migraine

Treatment of Pain Associated with Fibromyalgia

A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody in Patients with Active Rheumatoid Arthritis

Migraine Study in Adolescent Patients

Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina (T89 phase 2)

Clinical Trial of SB-509-0401 in Subjects with Diabetic Neuropathy

Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)

Study Evaluating EAA-090 in Adult Outpatients with Neuropathic Pain Associated with Diabetic Neuropathy

Here you’ll find a selection of our previous clinical research trials.
Explore the results and learn more about what we do.

BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients

Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients with Mild to Moderate HF

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)